Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 176 results found. Search for [ CDSCO ]

Results 40 to 60 of 176
BusinessToday.In
November 23, 2020
Coronavirus vaccine update: Adar Poonawalla, the CEO of Serum Institute had recently said that his company might sell a two-shot COVID-19 vaccine for around Rs 500-600 for the general public


BusinessToday.In
November 22, 2020
Bharat Biotech has started the phase- 3 trial of its potential COVID-19 vaccine, involving 26,000 volunteers this month across 25 centres in the country, including Hyderabad, Goa, Nagpur, Bhubaneswar, and Aligarh


BusinessToday.In
November 21, 2020
The participant was admitted to a hospital with viral pneumonitis, few days after being given the vaccine. He was discharged after a week.


BusinessToday.In
November 21, 2020
Bharat Biotech, the developer of India's indigenous vaccine Covaxin, has said that it is planning to enrol about 2,000 participants each in metros for Phase-3 trials of its COVID-19 vaccine that began earlier this week


Rajeev Dubey
November 20, 2020
Emboldened, firms indulge in a game of one-upmanship based on alarmingly low number of trials. Sputnik had been tried on only 20 patients before Gamaleya made the claim; Pfizer 120 and Moderna 95


BusinessToday.In
November 11, 2020
In a tweet, KS Dhatwalia, Principal Spokesperson, Press Bureau of Information, said that Union Minister Prakash Javadekar will brief media on Cabinet decisions at 3 pm today


PTI
October 26, 2020
IMS and SUM Hospital is among the 21 medical institutes selected across the country by the Indian Council for Medical Research (ICMR) where the third phase trial would be conducted


BusinessToday.In
October 23, 2020
Dr Reddy's Laboratories has been given permission to conduct the trails of Russian COVID-19 vaccine Sputnik V, though, the date and time of the test will be determined by the company


BusinessToday.In
October 18, 2020
Coronavirus vaccine: Meanwhile, the Drug Control General of India (DCGI) on Saturday approved Dr Reddy's proposal to conduct clinical trials for Sputnik V in India


BusinessToday.In
October 15, 2020
Apollo Hospitals Group Executive Vice-Chairperson Shobana Kamineni said that the group will work with the government in tandem to ensure that maximum number of people gets the coronavirus vaccine safe and fast


BusinessToday.In
October 15, 2020
Russian COVID-19 vaccine: Putin said on state TV that they have to increase production of first and second vaccines. \"We are continuing to cooperate with our foreign partners and will promote our vaccine abroad,\" he added


BusinessToday.In
October 14, 2020
Dr Reddy's has teamed up with Russian Development Investment Fund (RDIF) to conduct trials and distribute 100 million doses of Sputnik V in India


Rashi Bisaria
New Delhi, October 14, 2020
COVID-19 impact: Indian economy to shrink 10.3% in FY21, says IMFIndian economy will contract 10.3 per cent in the financial year 2020-21 as the country gradually climbs out of the coronavirus-induced lockdown, said the International Monetary Fund in its Wold Economic Outlook report released on Tuesday. This projection is substantially lower than the 4.5 per cent de-growth predicted by the internatonal financial instutution back in June, indicating challenges to economic growth as the pandem...


BusinessToday.In
October 13, 2020
\"We're expecting that early next year we should have vaccine in the country from maybe more than one source,\" says union health minister Harsh Vardhan


PTI
October 10, 2020
According to sources, the phase-2 trial of the Covaxin is going on and the second dose is yet to be given to volunteers at some sites


BusinessToday.In
October 9, 2020
Russian Health Minister Mikhail Murashko had said earlier that he expects to approve a Russian coronavirus vaccine developed by the Vector institute in mid-October


BusinessToday.In
New Delhi, October 9, 2020
India's drug regulator has declined a proposal from Hyderabad-based Dr Reddy's Laboratories Ltd to carry out a large study in the country to evaluate Russia's Sputnik-V coronavirus vaccine. The recommendations by an expert panel of the Central Drugs Standard Control Organisation (CDSCO) noted that safety and immunogenicity data from early-stage studies being conducted overseas is small, with no inputs available on Indian participants. Watch the video for more.Also Read: COVID-19 vaccine: Dr Reddy's asked to resubmit application for conducting trials of Sputnik V


BusinessToday.In
October 8, 2020
Coronavirus vaccine update: The CDSCO panel said that safety and immunogenicity data from early-stage trials of the Russian vaccine Sputnik V that were conducted overseas had a small number of participants


Reuters
October 6, 2020
The Hyderabad-based pharmaceutical company had applied to the Drugs Controller General of India (DCGI) late last week, seeking permission to conduct phase-3 human clinical trials of the Russian vaccine


PTI
August 25, 2020
Serum Institute of India has partnered with British-Swedish pharma company AstraZeneca for manufacturing the Covid-19 vaccine candidate, developed by the University of Oxford


PAGES 3 OF 9  12345